Dayno Jeffrey M.
PRESIDENT, CEO
Dayno Jeffrey M. has filed 2 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jan 26, 2026.
On the most recent filing, Dayno Jeffrey M. is listed as PRESIDENT, CEO at Harmony Biosciences Holdings, Inc. Inside the rolling window, Dayno Jeffrey M. reported no open-market purchases and 1 open-market sale totaling $1.0M in HRMY.
Companies traded
Other insiders at HRMY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Dayno Jeffrey M. made?
Dayno Jeffrey M. has filed 2 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Dayno Jeffrey M. trade?
Dayno Jeffrey M. has filed SEC Form 4 disclosures for 1 company, including HRMY.
When was Dayno Jeffrey M.'s most recent SEC Form 4 filing?
Dayno Jeffrey M.'s most recent SEC Form 4 filing on Tracefour is dated Jan 26, 2026.
What is Dayno Jeffrey M.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Dayno Jeffrey M. is listed as PRESIDENT, CEO.
What is Dayno Jeffrey M.'s total buy and sell value in the current window?
Inside the rolling retention window, Dayno Jeffrey M. bought $0 and sold $1.0M based on SEC Form 4 filings.
What was Dayno Jeffrey M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,933 HRMY shares on 2025-12-12, worth $1.0M, per SEC Form 4 filings.